Public Company

Natco Pharma receives the cancer drug boost

Natco Pharma touched a high of Rs 134 and a low of Rs 124. The stock finally ended with a 5.2% at Rs 129. Around 2.96 lakh shares were traded on the BSE as against the two-week average trade of 1.06 lakh shares. __________________________________________________ UCO Bank seeks shareholders" nod for fund raising Negative view on state-run oil cos: Fitch Jan cement sales in high double-digit The government stayed the Drug Controller of India order suspending the drug for not passing the test measuring endotoxin levels. Albupax is a nanatechnology-based drug. It consists of paclitaxel in an Albumin-bound nanoparticle form and is used in the treatment of breast cancer.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Mahesh Vyas: India Inc's Prowess
Mahesh Vyas / New Delhi January 2, 2010, 0:54 IST
Popular Articles

Sales not impacted by swine flu so far: Aditya Birla Retail
As a precautionary step against swine flu, Aditya Birla Retail has provided its employees with masks to be worn in stores and is making sure they get treated even for a mild disorder.

F&O OUTLOOK: Indecisiveness spreads to stocks futures
The Nifty traded in the positive territory for most part of the day. The index made an intra-day high of 5,167 but closed at 5,103, indicating caution at higher levels. This means the 5,182 level has acted as a strong resistance for the last four days with crucial support remaining at 5,080. It is difficult to predict when the market will move out of the current trading band as indecisiveness has now spread to stocks futures — most traded Nifty components, such as Tata Steel, Reliance Industries, Unitech, DLF, Tata Motors and Suzlon Energy, closed in a Doji pattern today.

© Copyright 2009